ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's cuts price of cardiovascular drug Cidmus
"Following the price reduction, Cidmus will be priced at Rs 29 for 50 mg (down from Rs 78.32); Rs 49 for 100 mg (down from Rs 83.86); Rs 79 for 200 mg (down from Rs 96.71) per tablet," the Hyderabad-based drug maker said in a statement.
Announcement as on 18 January 2023

Theranica partners with Dr Reddy's for marketing wearable Nerivio in India
A press release from Theranica on Tuesday said under the terms of the agreement, Dr. Reddy's will be responsible for the regulatory approval of Nerivio in India, after which it will exclusively market Nerivio in the country, manufactured and supplied by Th
Announcement as on 11 January 2023

Claims against Dr Reddy's over Revlimid in US dismissed
Dr Reddy's Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.
Announcement as on 29 December 2022

Dr Reddy#39;s shares gain after US dismisses claims against Revelimid
Revlimid, also known as lenalidomide, is an oral drug that is used for the treatment of multiple myeloma or blood cancer
Announcement as on 29 December 2022

Tata Motors enters BSE Sensex with effect from today, Dr Reddy’s Lab out
As per Trendlyne data, the highest target price for TaMo goes up to Rs 575, while the average target price estimate is Rs 495, an upside potential of 18.2% from the current prices. Out of the 29 analysts covering the stock, 21 have strong buy and buy ratin
Announcement as on 19 December 2022

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.89
  • 12Day Average: 13.69
  • 20Day Average: 13.96
  • 50Day Average: 13.59
  • 100Day Average: 13.68
  • 150Day Average: 13.73
  • 200Day Average: 13.8

RDY Indicators & signals

Indicator MACD (12,26,9)

13.45, 13.66, 0.01
Indicator MACD is in negative zone

Indicator ADX (14)

36, 20.51, 43.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Thu Jul 2026 12.70 12.66 to 12.85 -0.55% 0.61 times
15 Wed Jul 2026 12.77 12.75 to 12.95 -0.55% 0.68 times
14 Tue Jul 2026 12.84 12.70 to 12.95 -0.62% 0.92 times
13 Mon Jul 2026 12.92 12.92 to 13.27 -2.12% 0.79 times
10 Fri Jul 2026 13.20 13.06 to 13.70 -4.97% 0.95 times
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.69 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.43 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 1 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.44 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.8 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.3 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.24 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top